These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 20054283)
1. Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease. Chung MJ; Cheon JH; Kim SU; Park JJ; Kim TI; Kim NK; Kim WH J Clin Gastroenterol; 2010 Jul; 44(6):e116-22. PubMed ID: 20054283 [TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease. Jung YS; Hong SP; Kim TI; Kim WH; Cheon JH J Clin Gastroenterol; 2012; 46(5):e38-45. PubMed ID: 22298088 [TBL] [Abstract][Full Text] [Related]
3. Early versus late surgery in patients with intestinal Behçet disease. Jung YS; Hong SP; Kim TI; Kim WH; Cheon JH Dis Colon Rectum; 2012 Jan; 55(1):65-71. PubMed ID: 22156869 [TBL] [Abstract][Full Text] [Related]
4. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. Kim JS; Lim SH; Choi IJ; Moon H; Jung HC; Song IS; Kim CY Endoscopy; 2000 Aug; 32(8):635-40. PubMed ID: 10935793 [TBL] [Abstract][Full Text] [Related]
5. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease. Kim PS; Zlatanic J; Korelitz BI; Gleim GW Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725 [TBL] [Abstract][Full Text] [Related]
6. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808 [TBL] [Abstract][Full Text] [Related]
7. Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment. Bresci G; Parisi G; Capria A Colorectal Dis; 2008 Oct; 10(8):814-7. PubMed ID: 18834420 [TBL] [Abstract][Full Text] [Related]
8. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course. Choi CH; Kim TI; Kim BC; Shin SJ; Lee SK; Kim WH; Kim HS Dis Colon Rectum; 2006 Dec; 49(12):1849-59. PubMed ID: 17080284 [TBL] [Abstract][Full Text] [Related]
9. Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older? Lee JH; Cheon JH; Moon CM; Park JJ; Hong SP; Kim TI; Kim WH Digestion; 2010; 81(4):237-43. PubMed ID: 20110709 [TBL] [Abstract][Full Text] [Related]
10. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet's disease. Naganuma M; Iwao Y; Inoue N; Hisamatsu T; Imaeda H; Ishii H; Kanai T; Watanabe M; Hibi T Am J Gastroenterol; 2000 Oct; 95(10):2848-51. PubMed ID: 11051358 [TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
12. Oropharyngeal pemphigus vulgaris and clinical remission: a long-term, longitudinal study. Mignogna MD; Fortuna G; Leuci S; Ruoppo E Am J Clin Dermatol; 2010; 11(2):137-45. PubMed ID: 20141235 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy. Cherian PT; Cherian S; Singh P Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640 [TBL] [Abstract][Full Text] [Related]
15. Audit of the change of outcome of peptic ulcer disease following treatment of Helicobacter pylori. Jost C; Marbet UA Schweiz Med Wochenschr; 1998 Jan; 128(3):64-71. PubMed ID: 9498257 [TBL] [Abstract][Full Text] [Related]